Covered recipient · General Payments record
RACHEL EPSTEIN
Allopathic & Osteopathic Physicians Ophthalmology Cornea and External Diseases Specialist
General Payments · PY2019–2025
$6,409.30
- Reported across 110 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $769.50 | 16 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| GLAUKOS CORPORATION | $379.36 | 3 |
| Amgen Inc. | $132.82 | 6 |
| Alcon Vision LLC | $108.38 | 1 |
| Harrow Eye, LLC | $108.16 | 4 |
| ABBVIE INC. | $20.97 | 1 |
| Bausch & Lomb Americas Inc. | $19.81 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $20.97 | 02/25/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201821205 | CMS |
| Alcon Vision LLC | $108.38 | 01/22/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1207444781 | CMS |
| Amgen Inc. | $23.80 | 02/28/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228430892 | CMS |
| Amgen Inc. | $23.57 | 05/21/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228430898 | CMS |
| Amgen Inc. | $23.34 | 07/09/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228430894 | CMS |
| Amgen Inc. | $22.80 | 09/09/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228430896 | CMS |
| Amgen Inc. | $15.60 | 10/27/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228430890 | CMS |
| Amgen Inc. | $23.71 | 12/19/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228430888 | CMS |
| Bausch & Lomb Americas Inc. | $19.81 | 09/12/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1254866827 | CMS |
| Glaukos Corporation | $30.13 | 03/04/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1246408566 | CMS |
| Glaukos Corporation | $146.58 | 10/23/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1246408662 | CMS |
| Glaukos Corporation | $202.65 | 12/10/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1246408704 | CMS |
| Harrow Eye, LLC | $33.87 | 02/24/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1236218921 | CMS |
| Harrow Eye, LLC | $18.83 | 06/17/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1236218923 | CMS |
| Harrow Eye, LLC | $35.23 | 07/15/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1236218925 | CMS |
| Harrow Eye, LLC | $20.23 | 08/20/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1236218927 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024, 2025
- Source files
- Dataset page · Bulk file · PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024 , PY2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.